| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,679 |
14,220 |
$427K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,423 |
2,201 |
$108K |
| 11721 |
|
3,803 |
3,712 |
$59K |
| L3000 |
Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each |
384 |
135 |
$48K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
295 |
295 |
$22K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
342 |
282 |
$17K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
340 |
333 |
$7K |
| 11750 |
|
52 |
45 |
$5K |
| 73630 |
|
278 |
216 |
$5K |
| 20550 |
|
133 |
104 |
$4K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
23 |
13 |
$1K |
| 17110 |
|
26 |
26 |
$1K |
| 11765 |
|
14 |
12 |
$445.13 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
192 |
156 |
$198.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
179 |
144 |
$14.77 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
14 |
12 |
$4.40 |